ornithylaspartate has been researched along with rifamycins in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evdokimov, VV; Evdokimova, AG; Kovalenko, EV; Radzevich, AÉ; Tomova, AV; Zhukolenko, LV | 1 |
| Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B | 1 |
| Braddock, M; Chen, YP; Huang, GQ; Huang, S; Lin, YQ; Shi, KQ; Wang, LR; Zheng, MH; Zhu, GQ | 1 |
| Utzt, MJ | 1 |
| Henderson, PK; Herrera, JL | 1 |
| Sussman, NL | 1 |
| Petersen, KU | 1 |
4 review(s) available for ornithylaspartate and rifamycins
| Article | Year |
|---|---|
[Hepatic encephalopathy and liver transplantation].
Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2012 |
Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Dipeptides; Disaccharides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Mental Health; Neomycin; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin | 2015 |
Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What?
Topics: Dipeptides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Patient Selection; Probiotics; Rifamycins; Rifaximin; Severity of Illness Index; Sickness Impact Profile | 2015 |
Treatment of Overt Hepatic Encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Arteriovenous Fistula; Dipeptides; Gastrointestinal Agents; Glycerol; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure; Malnutrition; Ornithine; Phenylbutyrates; Probiotics; Rifamycins; Rifaximin | 2015 |
3 other study(ies) available for ornithylaspartate and rifamycins
| Article | Year |
|---|---|
[Optimization of treatment of patients with chronic cardiac insufficiency of the ischemic genesis and hobnail liver].
Topics: Aged; Anti-Infective Agents; Comorbidity; Dipeptides; Drug Combinations; Female; Heart; Heart Failure; Hepatic Encephalopathy; Humans; Liver; Male; Middle Aged; Rifamycins; Rifaximin | 2011 |
[In Process Citation].
Topics: Ammonia; Clinical Trials as Topic; Dipeptides; Early Diagnosis; Early Medical Intervention; Evidence-Based Medicine; Hepatic Encephalopathy; Humans; Lactulose; Prognosis; Rifamycins; Rifaximin | 2015 |
[Options in the treatment of hepatic encephalopathy].
Topics: Amino Acids, Branched-Chain; Ammonia; Anti-Bacterial Agents; Dipeptides; Hepatic Encephalopathy; Humans; Rifamycins; Rifaximin | 2015 |